Histoplasma capsulatum

Immunology of Fungal Infections

Volumn , Issue , 2007, Pages 409-426

  Nosanchuk, Joshua D ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 67249100768     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/1-4020-5492-0_18     Document Type: Chapter

References (130)

1. Allendoerfer, R., Biovin, G. P. et al. (1997) Modulation of immune responses in murine pulmonary histoplasmosis. J. Infect. Dis. 175(4), 905-14.
2. Allendoerfer, R. and Deepe, G. S. Jr. (1997) Intrapulmonary response to Histoplasma capsulatum in gamma interferon knockout mice. Infect. Immun. 65(7), 2564-9.
3. Allendoerfer, R. and Deepe, G. S. Jr. (1998) Blockade of endogenous TNF-alpha exacerbates primary and secondary pulmonary histoplasmosis by differential mechanisms. J. Immunol. 160(12), 6072-82.
4. Allendoerfer, R., Magee, D. M. et al. (1993) Transfer of protective immunity in murine histoplasmosis by a CD4+ T-cell clone. Infect. Immun. 61(2), 714-8.
5. Allendoerfer, R., Maresca, B. et al. (1996) Cellular immune responses to recombinant heat shock protein 70 from Histoplasma capsulatum. Infect. Immun. 64(10), 4123-8.
6. Allendorfer, R., Brunner, G. D. et al. (1999) Complex requirements for nascent and memory immunity in pulmonary histoplasmosis. J. Immunol. 162(12), 7389-96.
7. Arango, M., Cano, L. E. et al. (1990) Histoplasmosis y Criptococosis diseminada en pacientes con el sindrome de immunodeficiencia adaquira (SIDA). Acta. Medica. Colombiana 15(2), 84-91.
8. Arechavala, A. I., Robles, A. M. et al. (1993) [Value of direct and indirect diagnostic methods in systemic mycoses associated with AIDS]. Rev. Inst. Med. Trop. Sao. Paulo. 35(2), 163-9.
9. Bradsher, R. W. (1996) Histoplasmosis and blastomycosis. Clin. Infect Dis. 22(Suppl 2), S102-11.
10. Bromuro C., Torosantucci, A. et al. (2002) Interplay between protective and inhibitory antibodies dictates the outcome of experimentally disseminated candidiasis in recipients of a Candida albicans vaccine. Infect. Immun. 70(10), 5462-70.
11. Brummer, E., Kurita, N. et al. (1991) Killing of Histoplasma capsulatum by gamma-interferon-activated human monocyte-derived macrophages: evidence for a superoxide anion-dependent mechanism. J. Med. Microbiol. 35(1), 29-34.
12. Bullock, W. E. and Wright, S. D. (1987) Role of the adherence-promoting receptors, CR3, LFA-1, and p150, 95, in binding of Histoplasma capsulatum by human macrophages. J. Exp. Med. 165(1), 195-210.
13. Cain, J. A. and Deepe, G. S. Jr. (1998) Evolution of the primary immune response to Histoplasma capsulatum in murine lung. Infect. Immun. 66(4), 1473-81.
14. Cano, M. V. and Hajjeh, R. A. (2001) The epidemiology of histoplasmosis: a review. Semin. Respir. Infect. 16(2), 109-18.
15. Casadevall, A. and Pirofski, L. (2001) Host-pathogen interactions: the attributes of virulence. J. Infect. Dis. 184(3), 337-44.
16. Casadevall, A. and Pirofski, L. (2005) Insights into mechanisms of antibody-mediated immunity from studies with Cryptococcus neoformans. Curr. Mol. Med. 5(4), 421-33.
17. Casadevall, A. and Pirofski, L. A. (2002) What is a pathogen? Ann. Med. 34(1), 2-4.
18. Casadevall, A. and Pirofski, L. A. (2004) New concepts in antibody-mediated immunity. Infect Immun. 72(11), 6191-6.
19. Casadevall, A. and M. D. Scharff (1995) Return to the past: the case for antibody-based therapies in infectious diseases. Clin. Infect. Dis. 21(1), 150-61.
20. Centers For Disease Control and Prevention (1987) Revision of the CDC surveillance case definition for the acquired immunodeficiency syndrome. MMWR Morb. Mortal Wkly. Rept. 36(Suppl 1), 1S-15S.
21. Chandler, J. W. Jr., Smith, T. K. et al. (1969) Immology of the mycoses. II. Characterization of the immunoglobulin and antibody responses in histoplasmosis. J. Infect. Dis. 119(3), 247-54.
22. Da Rocha-Lima, H. (1912) Histoplasmosis und epizootic lymphanigitis. Arch. Schiffs Tropenhyg 16, 79-85.
23. Da Rocha-Lima, H. (1912-1913) Beitrag zur Kentnis der Blastoimykosen-Lymphangitis epizootica und Histoplasmosis. Zentralbl Bakteriol 67, 223-49.
24. Darling, S. (1906) A protozoan general infection producing pseudotubercules in the lungs and focal necrosis in the liver, spleen, and lymph nodes. JAMA 46, 1283-1285.
25. Davies, S. F., Khan, M. et al. (1978) Disseminated histoplasmosis in immunologically suppressed patients. Occurrence in a nonendemic area. Am. J. Med. 64(1), 94-100.
26. De Mondbreun, W. (1934) The cultivation and cultural characteristics of Darling's Histoplasma capsulatum. Am. J. Trop. Med. 93-118.
27. De Sanchez, S. B. and Carbonell, L. M. (1975) Immunological studies on Histoplasma capsulatum. Infect. Immun. 11(2), 387-94.
28. Deepe, G. S. Jr. (1994) Role of CD8+ T cells in host resistance to systemic infection with Histoplasma capsulatum in mice. J. Immunol. 152(7), 3491-500.
29. Deepe, G. S. Jr. (2005) Modulation of infection with Histoplasma capsulatum by inhibition of tumor necrosis factor-alpha activity. Clin. Infect. Dis. 41(Suppl 3), S204-7.
30. Deepe, G. S. Jr. and Gibbons, R. (2001) Protective efficacy of H antigen from Histoplasma capsulatum in a murine model of pulmonary histoplasmosis. Infect. Immun. 69(5), 3128-34.
31. Deepe, G. S. Jr., Gibbons, R. et al. (1999) Neutralization of endogenous granulocyte-macrophage colonystimulating factor subverts the protective immune response to Histoplasma capsulatum. J. Immunol. 163(9), 4985-93.
32. Deepe, G. S. Jr. and Gibbons, R. S. (2002) Cellular and molecular regulation of vaccination with heat shock protein 60 from Histoplasma capsulatum. Infect. Immun. 70(7), 3759-67.
33. Diercks, F. H., Shacklette, M. H. et al. (1965) Naturally occurring histoplasmosis among 935 bats collected in Panama and the Canal Zone, July 1961-February 1963. Am. J. Trop. Med. Hyg. 14(6), 1069-72.
34. Disalvo, A. F., Bigler, W. J. et al. (1970) Bat and soil studies for sources of histoplasmosis in Florida. Public Health Rep. 85(12), 1063-9.
35. Dubois, A., Janssens, P. et al. (1952) Un cas d'histoplasmose Africaine. Avec une note mycologique sur Histoplasma duboisii n sp por R. Vanbreuseghems. Am. Soc. Belg. Med. Trop. 32, 569-584.
36. Duncan, J. (1947) A unique form of Histoplasma. Tans. R. Soc. Trop. Med. Hyg. 40, 364-365.
37. Duncan, J. (1958) Tropical African histoplasmosis. Trans. R. Soc. Trop. Med. Hyg. 52, 468-474.
38. Edwards, L. B., Acquaviva, F. A. et al. (1969) An atlas of sensitivity to tuberculin, PPD-B, and histoplasmin in the United States. Am. Rev. Respir. Dis. 99(4): Suppl: 1-132.
39. Ehlers, S. (2005) Tumor necrosis factor and its blockade in granulomatous infections: differential modes of action of infliximab and etanercept? Clin. Infect. Dis. 41(Suppl 3), S199-203.
40. Eissenberg, L. G. and Goldman, W. E. (1987) Histoplasma capsulatum fails to trigger release of superoxide from macrophages. Infect Immun. 55(1), 29-34.
41. Eissenberg, L. G., Goldman, W. E. et al. (1993) Histoplasma capsulatum modulates the acidification of phagolysosomes. J. Exp. Med. 177(6), 1605-11.
42. Eissenberg, L. G., Schlesinger, P. H. et al. (1988) Phagosome-lysosome fusion in P388D1 macrophages infected with Histoplasma capsulatum. J. Leukoc. Biol. 43(6), 483-91.
43. Emmons, C. (1949) Isolation of Histoplasma capsulatum from soil. Public Health Rep. 64, 892-896.
44. Emmons, C. W., Klite, P. D. et al. (1966) Isolation of Histoplasma capsulatum from bats in the United States. Am. J. Epidemiol. 84(1), 103-9.
45. Fojtasek, M. F., Sherman, M. R. et al. (1993) Local immunity in lung-associated lymph nodes in a murine model of pulmonary histoplasmosis. Infect. Immun. 61(11), 4607-14.
46. Furcolow, M. L. (1963) Tests of immunity in histoplasmosis. N. Engl. J. Med. 268, 357-61.
47. Garcia, J. P. and Howard, D. H. (1971) Characterization of antigens from the yeast phase of Histoplasma capsulatum. Infect. Immun. 4(2), 116-25.
48. Garrison, R. G. and K. S. Boyd (1977) The fine structure of microconidial germination and vegetative cells of Histoplasma capsulatum. Ann. Microbiol. (Paris) 128(2), 135-49.
49. Garrison, R. G. and Boyd, K. S. (1978) Electron microscopy of yeastlike cell development from the microconidium of Histoplasma capsulatum. J. Bacteriol. 133(1), 345-53.
50. Gildea, L. A., Morris, R. E. et al. (2001) Histoplasma capsulatum yeasts are phagocytosed via very late antigen-5, killed, and processed for antigen presentation by human dendritic cells. J. Immunol. 166(2), 1049-56.
51. Goldman, M., Zackin, R. et al. (2004) Safety of discontinuation of maintenance therapy for disseminated histoplasmosis after immunologic response to antiretroviral therapy. Clin. Infect. Dis. 38(10), 1485-9. Epub 2004 Apr. 28.
52. Gomez, A. M., Bullock, W. E. et al. (1988) Role of L3T4+ T cells in host defense against Histoplasma capsulatum. Infect. Immun. 56(7), 1685-91.
53. Gomez, F. J., Allendoerfer, R. et al. (1995) Vaccination with recombinant heat shock protein 60 from Histoplasma capsulatum protects mice against pulmonary histoplasmosis. Infect Immun. 63(7), 2587-95.
54. Gomez, F. J., Cain, J. A. et al. (1998) Vbeta4 (+) T cells promote clearance of infection in murine pulmonary histoplasmosis. J. Clin. Invest. 102(5), 984-95.
55. Gomez, F. J., Woodward, E. O. et al. (2001) V beta 6+ and V beta 4+ T cells exert cooperative activity in clearance of secondary infection with Histoplasma capsulatum. J. Immunol. 166(4), 2855-62.
56. Goodwin, R. A. Jr., Owens, F. T. et al. (1976) Chronic pulmonary histoplasmosis. Medicine (Baltimore) 55(6), 413-52.
57. Goodwin, R. A. Jr., Shapiro, J. L. et al. (1980) Disseminated histoplasmosis: clinical and pathologic correlations. Medicine (Baltimore) 59(1), 1-33.
58. Goodwin, R. A., Loyd, J. E. et al. (1981) Histoplasmosis in normal hosts. Medicine (Baltimore) 60(4), 231-66.
59. Graybill, J. R. (1988) Histoplasmosis and AIDS. J. Infect. Dis. 158(3), 623-626.
60. Hajjeh, R. A., Pappas, P. G. et al. (2001) Multicenter case-control study of risk factors for histoplasmosis in human immunodeficiency virus-infected persons. Clin. Infect. Dis. 32(8), 1215-20.
61. Heinzel, F. P., Schoenhaut, D. S. et al. (1993) Recombinant interleukin 12 cures mice infected with Leishmania major. J. Exp. Med. 177(5), 1505-9.
62. Howard, D. H. (1967) Effect of temperature on the intracellular growth of Histoplasma capsulatum. J. Bacteriol. 93(1), 438-44.
63. Johnson, P. C., Khardori, N. et al. (1988) Progressive disseminated histoplasmosis in patients with acquired immunodeficiency syndrome. Am. J. Med. 85(2), 152-158.
64. Kaufman, L. (1992) Immunohistologic diagnosis of systemic mycoses: an update. Eur. J. Epidemiol. 8(3), 377-82.
65. Kaufman, L. (1992) Laboratory methods for the diagnosis and confirmation of systemic mycoses. Clin. Infect. Dis. 14(Suppl 1), S23-9.
66. Kimberlin, C. L., Hariri, A. R. et al. (1981) Interactions between Histoplasma capsulatum and macrophages from normal and treated mice: comparison of the mycelial and yeast phases in alveolar and peritoneal macrophages. Infect. Immun. 34(1), 6-10.
67. Kurita, N., Brummer, E. et al. (1991) Antifungal activity of murine polymorphonuclear neutrophils against Histoplasma capsulatum. J. Med. Vet. Mycol. 29(3), 133-43.
68. Kurita, N., Terao, K. et al. (1991) Resistance of Histoplasma capsulatum to killing by human neutrophils. Evasion of oxidative burst and lysosomal-fusion products. Mycopathologia 115(3), 207-13.
69. Kwon-Chung, K. J. (1972) Emmonsiella capsulata: perfect state of Histoplasma capsulatum. Science 177(46), 368-9.
70. Kwon-Chung, K. J. (1975) Perfect state (Emmonsiella capsulata) of the fungus causing large-form African histoplasmosis. Mycologia 67(5), 980-90.
71. Kwon-Chung, K. J. and Bennett, J. E. (1992) Histoplasmosis. Medical Mycology. Kwon-Chung K. J. and Bennett J. E. Philadelphia, Lea and Febiger: 464-513.
72. Lane, T. E., Wu-Hsieh, B. A. et al. (1991) Iron limitation and the gamma interferon-mediated antihistoplasma state of murine macrophages. Infect. Immun. 59(7), 2274-8.
73. Lane, T. E., Wu-Hsieh, B. A. et al. (1993) Gamma interferon cooperates with lipopolysaccharide to activate mouse splenic macrophages to an antihistoplasma state. Infect. Immun. 61(4), 1468-73.
74. Lane, T. E., Wu-Hsieh, B. A. et al. (1994) Antihistoplasma effect of activated mouse splenic macrophages involves production of reactive nitrogen intermediates. Infect. Immun. 62(5), 1940-5.
75. Lee, J. H., Slifman, N. R. et al. (2002) Life-threatening histoplasmosis complicating immunotherapy with tumor necrosis factor alpha antagonists infliximab and etanercept. Arthritis Rheum. 46(10), 2565-70.
76. Lelouard, H., Gatti, E. et al. (2002) Transient aggregation of ubiquitinated proteins during dendritic cell maturation. Nature 517(6885), 177-182.
77. Lenhart, S., Schafer, M. et al. (2004) Histoplasmosis: protecting workers at risk. Atlanta, Georgia, Center for Disease Control and Prevention: 39.
78. Limaye, A. P., Connolly, P. A. et al. (2000) Transmission of Histoplasma capsulatum by organ transplantation. N. Engl. J. Med. 343(16), 1163-6.
79. Lin, J. S. and Wu-Hsieh, B. A. (2004). Functional T cells in primary immune response to histoplasmosis. Int. Immunol. 16(11), 1663-73. Epub 2004 Sep. 27.
80. Lin, J. S., Yang, C. W. et al. (2005) Dendritic cells cross-present exogenous fungal antigens to stimulate a protective CD8 T cell response in infection by Histoplasma capsulatum. J. Immunol. 174(10), 6282-91.
81. Luby, J. P., Southern, P. M. Jr., et al. (2005) Recurrent exposure to Histoplasma capsulatum in modern air-conditioned buildings. Clin. Infect. Dis. 41(2), 170-6. Epub 2005 Jun. 7.
82. Maresca, B. and Kobayashi, G. S. (1989) Dimorphism in Histoplasma capsulatum: a model for the study of cell differentiation in pathogenic fungi. Microbiol. Rev. 53(2), 186-209.
83. Medoff, G., Kobayashi, G. S. et al. (1987) Morphogenesis and pathogenicity of Histoplasma capsulatum. Infect. Immun. 55(6), 1355-8.
84. Minamoto, G. and Armstrong, D. (1988) Fungal infections in AIDS. Histoplasmosis and coccidioidomycosis. Infect. Dis. Clin. North Am. 2(2), 447-56.
85. Mirza, S. A., Phelan, M. et al. (2003) The changing epidemiology of cryptococcosis: an update from population-based active surveillance in 2 large metropolitan areas, 1992-2000. Clin. Infect. Dis. 36(6), 789-94.
86. Murillo, J. and Castro, K. G. (1994) HIV infection and AIDS in Latin America. Epidemiologic features and clinical manifestations. Infect. Dis. Clin. North Am. 8(1), 1-11.
87. Newman, S. L., Bucher, C. et al. (1990) Phagocytosis of Histoplasma capsulatum yeasts and microconidia by human cultured macrophages and alveolar macrophages. Cellular cytoskeleton requirement for attachment and ingestion. J. Clin. Invest. 85(1), 223-30.
88. Newman, S. L. and Gootee, L. (1992) Colony-stimulating factors activate human macrophages to inhibit intracellular growth of Histoplasma capsulatum yeasts. Infect Immun. 60(11), 4593-7.
89. Newman, S. L., Gootee, L. et al. (1993) Human neutrophil-mediated fungistasis against Histoplasma capsulatum. Localization of fungistatic activity to the azurophil granules. J. Clin. Invest. 92(2), 624-31.
90. Nosanchuk, J. D., Steenbergen, J. N. et al. (2003) Antibodies to a cell surface histone-like protein protect against Histoplasma capsulatum. J. Clin. Invest. 112(8), 1164-75.
91. Nosanchuk, J. D., Steenbergen, J. N. et al. (2003) Protective monoclonal antibodies to Histoplasma capsulatum. 103rd Annual Meeting of the American Society of Microbiology, Washington, DC, ASM press.
92. Pirofski, L. A. and Casadevall, A. (2002) The meaning of microbial exposure, infection, colonisation, and disease in clinical practice. Lancet. Infect. Dis. 2(10), 628-35.
93. Retallack, D. M. and Woods, J. P. (1999) Molecular epidemiology, pathogenesis, and genetics of the dimorphic fungus Histoplasma capsulatum. Microbes Infect. 1(10), 817-25.
94. Rivolta, S. and Micellone, I. (1883) Del farcino criptococcio. Giorn Anata Tatol Animali Domestici 15, 143-162.
95. Romani, L., Mencacci, A. et al. (1992) Neutralizing antibody to interleukin 4 induces systemic protection and T helper type 1-associated immunity in murine candidiasis. J. Exp. Med. 176(1), 19-25.
96. Rosenthal, J., Brandt, K. D. et al. (1983) Rheumatologic manifestations of histoplasmosis in the recent Indianapolis epidemic. Arthritis Rheum. 26(9), 1065-70.
97. Sa-Nunes, A., Medeiros, A. I. et al. (2005) Efficacy of cell-free antigens in evaluating cell immunity and inducing protection in a murine model of histoplasmosis. Microbes Infect. 7(4), 584-92. Epub 2005 Mar. 14.
98. Sathapatayavongs, B., Batteiger, B. E. et al. (1983) Clinical and laboratory features of disseminated histoplasmosis during two large urban outbreaks. Medicine (Baltimore) 62(5), 263-70.
99. Sau, K., Mambula, S. S. et al. (2003) The antifungal drug amphotericin B promotes inflammatory cytokine release by a Toll-like receptor- and CD14-dependent mechanism. J. Biol. Chem. 278(39), 37561-8.
100. Scheckelhoff, M. and Deepe, G. S. Jr. (2002) The protective immune response to heat shock protein 60 of Histoplasma capsulatum is mediated by a subset of V beta 8.1/8.2+ T cells. J. Immunol. 169(10), 5818-26.
101. Shacklette, M. H., Diercks, F. H. et al. (1962) Histoplasma capsulatum recovered from bat tissues. Science 135, 1135.
102. Shacklette, M. H. and Hasenclever, H. F. (1969) Variation of rates of natural infection with Histoplasma capsulatum in bats. Am. J. Trop. Med. Hyg. 18(1), 53-7.
103. Shallot, J., Pursell, K. J. et al. (1997) Disseminated histoplasmosis after orthotopic liver transplantation. Liver Transpl. Surg. 3(4), 433-4.
104. Strasser, J. E., Newman, S. L. et al. (1999) Regulation of the macrophage vacuolar ATPase and phagosome-lysosome fusion by Histoplasma capsulatum. J. Immunol. 162(10), 6148-54.
105. Tewari, R. P., Sharma, D. et al. (1977) Adoptive transfer of immunity from mice immunized with ribosomes or live yeast cells of Histoplasma capsulatum. Infect. Immun. 15(3), 789-95.
106. Tripp, C. S., Gately, M. K. et al. (1994) Neutralization of IL-12 decreases resistance to Listeria in SCID and C. B-17 mice. Reversal by IFN-gamma. J. Immunol. 152(4), 1883-7.
107. Vail, G. M., Young, R. S. et al. (2002) Incidence of histoplasmosis following allogeneic bone marrow transplant or solid organ transplant in a hyperendemic area. Transpl. Infect Dis. 4(3), 148-51.
108. Watanabe, M., Hotchi, M. et al. (1988) An autopsy case of disseminated histoplasmosis probably due to infection from a renal allograft. Acta. Pathol. Jpn. 38(6), 769-80.
109. Wheat, J. (1994) Histoplasmosis and coccidioidomycosis in individuals with AIDS. A clinical review. Infect. Dis. Clin. North Am. 8(2), 467-82.
110. Wheat, J. (1996) Histoplasmosis in the acquired immunodeficiency syndrome. Curr. Top. Med. Mycol. 7(1), 7-18.
111. Wheat, J. (1997) Histoplasmosis. Experience during outbreaks in Indianapolis and review of the literature. Medicine (Baltimore) 76(5), 339-54.
112. Wheat, J., Sarosi, G. et al. (2000) Practice guidelines for the management of patients with histoplasmosis. Infectious Diseases Society of America. Clin. Infect. Dis. 30(4), 688-95.
113. Wheat, L. J. (1992) Histoplasmosis in Indianapolis. Clin. Infect Dis. 14(Suppl 1), S91-9.
114. Wheat, L. J., Batteiger, B. E. et al. (1990) Histoplasma capsulatum infections of the central nervous system. A clinical review. Medicine (Baltimore) 69(4), 244-60.
115. Wheat, L. J., Chetchotisakd, P. et al. (2000) Factors associated with severe manifestations of histoplasmosis in AIDS. Clin. Infect Dis. 30(6), 877-81.
116. Wheat, L. J., Connolly-Stringfield, P. A. et al. (1990) Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature. Medicine (Baltimore) 69(6), 361-74.
117. Wheat, L. J. and Kauffman, C. A. (2003) Histoplasmosis. Infect. Dis. Clin. North Am. 17(1), 1-19, vii.
118. Wheat, L. J., Wass, J. et al. (1984) Cavitary histoplasmosis occurring during two large urban outbreaks. Analysis of clinical, epidemiologic, roentgenographic, and laboratory features. Medicine (Baltimore) 63(4), 201-9.
119. Williams, B., Fojtasek, M. et al. (1994) Diagnosis of histoplasmosis by antigen detection during an outbreak in Indianapolis, Ind. Arch. Pathol. Lab. Med. 118(12), 1205-8.
120. Williams, D. M., Graybill, J. R. et al. (1978) Histoplasma capsulatum infection in nude mice. Infect. Immun. 21(3), 973-7.
121. Wolf, J. E., Abegg, A. L. et al. (1989) Effects of Histoplasma capsulatum on murine macrophage functions: inhibition of macrophage priming, oxidative burst, and antifungal activities. Infect. Immun. 57(2), 513-9.
122. Wolf, J. E., Kerchberger, V. et al. (1987) Modulation of the macrophage oxidative burst by Histoplasma capsulatum. J. Immunol. 138(2), 582-6.
123. Wong, S. Y. and Allen, D. M. (1992) Transmission of disseminated histoplasmosis via cadaveric renal transplantation: case report. Clin. Infect. Dis. 14(1), 232-4.
124. Wood, K. L., Hage, C. A. et al. (2003) Histoplasmosis after treatment with anti-tumor necrosis factor-alpha therapy. Am. J. Respir. Crit. Care. Med. 167(9), 1279-82.
125. Woods, J. P. (2002) Histoplasma capsulatum molecular genetics, pathogenesis, and responsiveness to its environment. Fungal. Genet. Biol. 35(2), 81-97.
126. Wu-Hsieh, B. A. and Howard, D. H. (1987) Inhibition of the intracellular growth of Histoplasma capsulatum by recombinant murine gamma interferon. Infect. Immun. 55(4), 1014-6.
127. Wuthrich, M., Filutowicz, H. I. et al. (2003) Vaccine Immunity to Pathogenic Fungi Overcomes the Requirement for CD4 Help in Exogenous Antigen Presentation to CD8+ T Cells: Implications for Vaccine Development in Immune-deficient Hosts. J. Exp. Med. 197(11), 1405-16.
128. Zhou, P., Miller, G. et al. (1998) Factors involved in regulating primary and secondary immunity to infection with Histoplasma capsulatum: TNF-alpha plays a critical role in maintaining secondary immunity in the absence of IFN-gamma. J. Immunol. 160(3), 1359-68.
129. Zhou, P., Sieve, M. C. et al. (1995) IL-12 prevents mortality in mice infected with Histoplasma capsulatum through induction of IFN-gamma. J. Immunol. 155(2), 785-95.
130. Zhou, P., Sieve, M. C. et al. (1997) Interleukin-12 modulates the protective immune response in SCID mice infected with Histoplasma capsulatum. Infect. Immun. 65(3), 936-42.